Finance
Results: 433-444 of 37855

New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday

Align Partners Issues Third Public Shareholder Letter and Submits Formal Shareholder Proposals to Coway









